Table 2. Crystal volume index (CVI) in untreated and cysteamine treated eyes. .
| Eye ID | CVI at baseline (Mean±SD) | CVI after treatment (Mean±SD) | % change |
|---|---|---|---|
|
Untreated | |||
| 246 OD |
SCAR |
SCAR |
SCAR |
| 246 OS |
0.76±0.13 |
SCAR |
SCAR |
| 247 OD |
0.44±0.06 |
SCAR |
SCAR |
| 247 OS |
0.41±0.15 |
1.77±0.52 |
336 |
| 275 OD |
0.25±0.06 |
0.40±0.07 |
61 |
| 275 OS |
0.24±0.03 |
0.93±0.18 |
283 |
| 156 OD |
SCAR |
SCAR |
SCAR |
| 156 OS |
3.48±0.32 |
3.92±0.59 |
12 |
| 277 OD |
0.46±0.26 |
0.78±0.45 |
67 |
| 277 OS |
0.53±0.27 |
0.67±0.39 |
25 |
| Mean CVI |
0.82 |
1.41 |
173% |
|
Cysteamine treated | |||
| 276 OD |
0.38±0.13 |
0.41±0.17 |
9 |
| 276 OS |
0.77±0.40 |
0.60±0.19 |
-21 |
| 278 OD |
0.43±0.09 |
0.49±0.08 |
16 |
| 278 OS |
0.48±0.01 |
0.37±0.17 |
-22 |
| 279 OD |
0.25±0.15 |
0.60±0.13 |
137 |
| 279 OS |
0.17±0.11 |
0.28±0.13 |
65 |
| 249 OS |
0.82±0.26 |
0.73±0.01 |
-10 |
| 249 OD |
2.45±0.53 |
1.13±0.55 |
-53 |
| 245 OD |
0.55±0.17 |
2.87±2.32 |
416 |
| 245 OS |
SCAR |
SCAR |
SCAR |
| Mean CVI | 0.70 | 0.83 | 15% |